{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:21:04Z","timestamp":1792092064552,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clnesp.2024.09.032","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T11:19:18Z","timestamp":1729336758000},"page":"307-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Nutrition in phenylketonuria"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7646-2517","authenticated-orcid":false,"given":"Saeedeh","family":"Talebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Eshraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-022-00398-9","article-title":"Genetic etiology and clinical challenges of phenylketonuria","volume":"16","author":"Elhawary","year":"2022","journal-title":"Hum Genom"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.clnesp.2024.09.032_bib3","article-title":"Recent advances in phenylketonuria: a review","volume":"15","author":"Vinueza","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clnesp.2024.09.032_bib4","author":"Stone","year":"2018","journal-title":"Phenylketonuria"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib5","first-page":"49","article-title":"Phenylketonuria: translating research into novel therapies","volume":"3","author":"Ho","year":"2014","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.clnesp.2024.09.032_bib6","first-page":"1667","article-title":"Hyperphenylalaninemia: phenylalanine hydroxylase deficiency","author":"Cr","year":"2001","journal-title":"Metabol Molecular Bases Inherited Dis"},{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/ijns9010015","article-title":"Current state and innovations in newborn screening: continuing to do good and avoid harm","volume":"9","author":"la Marca","year":"2023","journal-title":"Int J Neonatal Screening"},{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-018-0890-7","article-title":"Can untreated PKU patients escape from intellectual disability? A systematic review","volume":"13","author":"Van Vliet","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0736-5748(96)00081-0","article-title":"Effect of experimental hyperphenylalaninemia on the postnatal rat brain","volume":"15","author":"Ushakova","year":"1997","journal-title":"Int J Dev Neurosci"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0925-4439(01)00112-0","article-title":"Experimental hyperphenylalaninemia provokes oxidative stress in rat brain","volume":"1586","author":"Hagen","year":"2002","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.clnesp.2024.09.032_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10545-013-9650-y","article-title":"Tract-based evaluation of white matter damage in individuals with early-treated phenylketonuria","volume":"37","author":"Peng","year":"2014","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.clnesp.2024.09.032_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2005.05.013","article-title":"Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria","volume":"86","author":"Hennermann","year":"2005","journal-title":"Mol Genet Metabol"},{"issue":"4","key":"10.1016\/j.clnesp.2024.09.032_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ymgme.2019.09.004","article-title":"Phenylalanine hydroxylase genotype-phenotype associations in the United States: a single center study","volume":"128","author":"Rajabi","year":"2019","journal-title":"Mol Genet Metabol"},{"issue":"9","key":"10.1016\/j.clnesp.2024.09.032_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.earlhumdev.2008.01.003","article-title":"Evaluation of neonatal BH4 loading test in neonates screened for hyperphenylalaninemia","volume":"84","author":"Feillet","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.clnesp.2024.09.032_bib15","article-title":"Conventional phenylketonuria treatment","volume":"4","author":"Sara","year":"2019","journal-title":"J\u00a0Inborn Errors of Metabol Screening"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2013.179","article-title":"Recommendations for the nutrition management of phenylalanine hydroxylase deficiency","volume":"16","author":"Singh","year":"2014","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-8223(94)90373-5","article-title":"Breast-feeding in the management of the newborn with phenylketonuria: a practical approach to dietary therapy","volume":"94","author":"Greve","year":"1994","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"47","key":"10.1016\/j.clnesp.2024.09.032_bib18","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.15585\/mmwr.mm6947a4","article-title":"Timing of introduction of complementary foods\u2014United States, 2016\u20132018","volume":"69","author":"Chiang","year":"2020","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"4","key":"10.1016\/j.clnesp.2024.09.032_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1025150901439","article-title":"Free use of fruits and vegetables in phenylketonuria","volume":"26","author":"Mac Donald","year":"2003","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.clnesp.2024.09.032_bib20","series-title":"Low protein cookery for phenylketonuria","author":"Schuett","year":"1997"},{"issue":"5","key":"10.1016\/j.clnesp.2024.09.032_bib21","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.clnu.2023.03.007","article-title":"A\u00a0food pyramid for adult patients with phenylketonuria and a systematic review on the current evidences regarding the optimal dietary treatment of adult patients with PKU","volume":"42","author":"Rondanelli","year":"2023","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3177\/jnsv.65.264","article-title":"Effects of cooking methods on free amino acid contents in vegetables","volume":"65","author":"Ito","year":"2019","journal-title":"J\u00a0Nutr Sci Vitaminol"},{"issue":"6","key":"10.1016\/j.clnesp.2024.09.032_bib23","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/nu12061887","article-title":"Aspartame and Phe-containing degradation products in soft drinks across Europe","volume":"12","author":"van Vliet","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/ajcn\/84.2.371","article-title":"Absorbability and utility of calcium in mineral waters","volume":"84","author":"Heaney","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"Van Wegberg","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.clnesp.2024.09.032_bib26","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/nu12061772","article-title":"Vitamin K status in adherent and non-adherent patients with phenylketonuria: a cross-sectional study","volume":"12","author":"Mozrzymas","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3945\/ajcn.110.009456","article-title":"Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies","volume":"95","author":"Prick","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-021-02108-5","article-title":"Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy","volume":"16","author":"Rohde","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.clnesp.2024.09.032_bib29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ajcn\/79.6.1078","article-title":"Energy requirements during pregnancy based on total energy expenditure and energy deposition","volume":"79","author":"Butte","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2024.09.032_bib30","article-title":"Comparison of phenylalanine tolerance in singleton and twin pregnancies in patients with phenylketonuria","volume":"48","author":"Hozyasz","year":"2020","journal-title":"J\u00a0Int Med Res"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2012.04.004","article-title":"Recommendations for the use of sapropterin in phenylketonuria","volume":"106","author":"Cunningham","year":"2012","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.clnesp.2024.09.032_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/8904_2014_365","article-title":"Maternal phenylketonuria: long-term outcomes in offspring and post-pregnancy maternal characteristics","volume":"21","author":"Waisbren","year":"2015","journal-title":"JIMD Reports"},{"issue":"8","key":"10.1016\/j.clnesp.2024.09.032_bib34","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1515\/jpem-2018-0503","article-title":"Response to sapropterin hydrochloride (Kuvan\u00ae) in children with phenylketonuria (PKU): a clinical trial","volume":"32","author":"Eshraghi","year":"2019","journal-title":"J\u00a0Pediatr Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ymgme.2021.01.001","article-title":"Long-term preservation of intellectual functioning in sapropterin-treated infants and young children with phenylketonuria: a seven-year analysis","volume":"132","author":"Waisbren","year":"2021","journal-title":"Mol Genet Metabol"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib36","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/nu13031040","article-title":"Protein substitute requirements of patients with phenylketonuria on BH4 treatment: a systematic review and meta-analysis","volume":"13","author":"Ilgaz","year":"2021","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.clnesp.2024.09.032_bib37","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.3390\/nu14183874","article-title":"Dietary liberalization in tetrahydrobiopterin-treated PKU patients: does it improve outcomes?","volume":"14","author":"Evers","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.09.032_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10545-010-9216-1","article-title":"Large neutral amino acids in the treatment of PKU: from theory to practice","volume":"33","author":"van Spronsen","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"11","key":"10.1016\/j.clnesp.2024.09.032_bib39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0002-8223(02)90346-9","article-title":"Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.(Commentary)","volume":"102","author":"Trumbo","year":"2002","journal-title":"J\u00a0Am Diet Assoc"},{"issue":"4","key":"10.1016\/j.clnesp.2024.09.032_bib40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/nu12041092","article-title":"Large neutral amino acids (LNAAs) supplementation improves neuropsychological performances in adult patients with phenylketonuria","volume":"12","author":"Scala","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1096-7192(03)00078-7","article-title":"Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment","volume":"79","author":"Koch","year":"2003","journal-title":"Mol Genet Metabol"},{"issue":"8","key":"10.1016\/j.clnesp.2024.09.032_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160892","article-title":"Evaluation of tetrahydrobiopterin therapy with large neutral amino acid supplementation in phenylketonuria: effects on potential peripheral biomarkers, melatonin and dopamine, for brain monoamine neurotransmitters","volume":"11","author":"Yano","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clnesp.2024.09.032_bib43","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jpeds.2012.10.015","article-title":"Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: a new biomarker","volume":"162","author":"Yano","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnesp.2024.09.032_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40259-018-0292-3","article-title":"Pegvaliase: first global approval","volume":"32","author":"Markham","year":"2018","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.clnesp.2024.09.032_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol Genet Metabol"},{"issue":"8","key":"10.1016\/j.clnesp.2024.09.032_bib46","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jand.2012.05.004","article-title":"Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino acid\u2013based medical foods for nutrition management of phenylketonuria","volume":"112","author":"Van Calcar","year":"2012","journal-title":"J\u00a0Acad Nutr Diet"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","article-title":"Gene-based therapies for neurodegenerative diseases","volume":"24","author":"Sun","year":"2021","journal-title":"Nat Neurosci"},{"issue":"10","key":"10.1016\/j.clnesp.2024.09.032_bib48","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1089\/hum.2019.111","article-title":"State-of-the-art 2019 on gene therapy for phenylketonuria","volume":"30","author":"Grisch-Chan","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.clnesp.2024.09.032_bib49","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/genes11101113","article-title":"Delivery approaches for therapeutic genome editing and challenges","volume":"11","author":"Ates","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.clnesp.2024.09.032_bib50","article-title":"Starting the conversation on gene therapy for phenylketonuria: current perspectives of patients, caregivers, and advocates","volume":"31","author":"Regier","year":"2022","journal-title":"Molecular Genetics and Metabol Rep"},{"issue":"3","key":"10.1016\/j.clnesp.2024.09.032_bib51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","article-title":"Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis","volume":"33","author":"Albrecht","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"10.1016\/j.clnesp.2024.09.032_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","article-title":"Phenylketonuria Scientific Review Conference: state of the science and future research needs","volume":"112","author":"Camp","year":"2014","journal-title":"Mol Genet Metabol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724013366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724013366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:44:19Z","timestamp":1733143459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724013366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"alternative-id":["S2405457724013366"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.09.032","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition in phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}